Bronchiectasis is a clinical and radiological diagnosis associated with cough, sputum
production and recurrent respiratory infections. The clinical presentation inevitably overlaps …

The excessive and persistent inflammatory response to external or endogenous noxae is
likely the common pathogenic mechanism to most chronic airway diseases. Among these …

Bronchiectasis refers to abnormal dilatation of the bronchi. Airway dilatation can lead to
failure of mucus clearance and increased risk of infection. Pathophysiological mechanisms …

The diagnostic label “bronchiectasis” describes the existence of localised and permanent
airway dilation, but when used to describe a disease it includes a heterogeneous group of …

Bronchiectasis, which was once thought to be an orphan disease, is now being recognized
with increasing frequency around the world. Patients with bronchiectasis have chronic …

Background In the 2014 Global initiative for chronic Obstructive Lung Disease guidelines,
bronchiectasis was for the first time defined as a comorbidity of chronic obstructive …

The nonrecognition of asthma-associated comorbidities is often responsible for the
therapeutic failure and the worsening of symptoms, and it is associated with frequent …

Bronchiectasis is a common but long-neglected disease in China, causing a substantial
disease burden both to patients and to society. The overall prevalence of physician …

Airway diseases are highly prevalent worldwide; however, the prevalence of these diseases
is underestimated. Although these diseases present several common characteristics, they …

Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no
approved therapies and few large-scale, representative epidemiological studies. The …